These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


333 related items for PubMed ID: 19844849

  • 21. Interscience Conference on Antimicrobial Agents and Chemotherapy--49th annual meeting. Part 1. 11-15 September 2009, San Francisco, CA, USA.
    Turner B, Murch L.
    IDrugs; 2009 Nov; 12(11):667-9. PubMed ID: 19844846
    [Abstract] [Full Text] [Related]

  • 22. Cardiovascular and renal developments: patent highlights January to June 2006.
    Mucke HA.
    Curr Opin Investig Drugs; 2006 Sep; 7(9):792-8. PubMed ID: 17002256
    [Abstract] [Full Text] [Related]

  • 23. Society for Neuroscience - 39th Annual Meeting. Part 1 - Novel therapies for the treatment of CNS disorders and pain.
    Al-Shamahi A, Kirkham K, Hookes L.
    IDrugs; 2009 Dec; 12(12):731-3. PubMed ID: 19943210
    [Abstract] [Full Text] [Related]

  • 24. European Society of Gene & Cell Therapy--17th annual congress.
    Chuah M.
    IDrugs; 2010 Feb; 13(2):63-5. PubMed ID: 20127551
    [Abstract] [Full Text] [Related]

  • 25. RNAi for Developing Targeted Therapeutics--CHI's Third Annual Meeting.
    Plane G.
    IDrugs; 2010 Jan; 13(1):20-2. PubMed ID: 20024842
    [Abstract] [Full Text] [Related]

  • 26. The role of natural products in drug discovery and development in the new millennium.
    Harvey A.
    IDrugs; 2010 Feb; 13(2):70-2. PubMed ID: 20127553
    [Abstract] [Full Text] [Related]

  • 27. Translating molecular target into drug therapy in cardiovascular disease.
    Bril A, Avkiran M.
    Curr Opin Pharmacol; 2008 Apr; 8(2):111-3. PubMed ID: 18294914
    [No Abstract] [Full Text] [Related]

  • 28. Ion Channels as Therapeutic Targets--CHI's Fourth Annual Conference.
    Thorneloe KS.
    IDrugs; 2010 Jan; 13(1):16-9. PubMed ID: 20024841
    [Abstract] [Full Text] [Related]

  • 29. A report from the European Society of Cardiology Congress 2013 (August 31-September 4, 2013 - Amsterdam, the Netherlands).
    Rabasseda X.
    Drugs Today (Barc); 2013 Sep; 49(9):575-91. PubMed ID: 24086953
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Medicinal Chemistry - XXIst International Symposium.
    Chan D.
    IDrugs; 2010 Nov; 13(11):749-52. PubMed ID: 21046517
    [Abstract] [Full Text] [Related]

  • 34. Biomarkers, atherosclerosis and cardiovascular events.
    Rosenson RS.
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):619-22. PubMed ID: 18510479
    [Abstract] [Full Text] [Related]

  • 35. Terrapinn's world influenza congress Europe 2009. Part 1.
    Veryard C.
    IDrugs; 2010 Feb; 13(2):76-7. PubMed ID: 20127555
    [Abstract] [Full Text] [Related]

  • 36. Recent Developments in Wound Management: intelligent biomaterials to novel antimicrobials. 24 September 2009, London, UK.
    Martin C.
    IDrugs; 2009 Nov; 12(11):695-8. PubMed ID: 19844855
    [Abstract] [Full Text] [Related]

  • 37. Drug Development for Neurodegenerative Diseases--a marcus evans conference. Expediting drugs to the market for neurodegenerative disease indications through novel translational efforts, regulatory clarity, and sound trial design. 7-8 April 2009, Boston, MA, USA.
    Morimoto B.
    IDrugs; 2009 Jun; 12(6):349-52. PubMed ID: 19517313
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cardiovascular disease drug discovery.
    Persidis A.
    Nat Biotechnol; 1999 Sep; 17(9):930-1. PubMed ID: 10471943
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.